News

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.
Scott Bok, the former board chair of the University of Pennsylvania, breaks down the financial risks and implications that ...
"It creates opportunity, which is terrific, but it also creates volatility," said Greg Case, CEO of Aon, talking about the ...
JGBs consolidated in morning Tokyo session ahead of Japanese Finance Ministry’s auction today of 800 billion yen of 20-year sovereign bonds.
"The economic implications for the U.S. are profound," said Greg Case, CEO of Aon.
A government board, whose members included Camp Mystic’s co-owner, contracted with a company to better spot danger on the ...
Workers struggling with mental illness are denied disability benefits more often than those with physical conditions, data ...
We’re accomplishing more, in less time, with artificial intelligence, but that creates a new workplace conflict.
Five countries whose leaders held talks with Trump at the White House were sent a U.S. proposal to accept deportees, document ...
Gold edged higher in the early Asian session amid U.S. tariff concerns that typically enhance the safe-haven allure of the precious metal.
Elsewhere in financial markets, drugmaker Merck strikes a roughly $10 billion deal to buy Verona Pharma. The Justice Department’s criminal healthcare-fraud unit investigates UnitedHealth’s Medicare ...